Bank of New York Mellon’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.35M | Buy |
|
|||||
|
2025
Q2 | $902K | Buy |
|
|||||
|
2025
Q1 | $82.6K | Buy |
|
|||||
|
2024
Q4 | $116K | Hold |
|
|||||
|
2024
Q3 | $101K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $430K | Sell |
|
|||||
|
2023
Q4 | $425K | Sell |
|
|||||
|
2023
Q3 | $814K | Sell |
|
|||||
|
2023
Q2 | $3.55M | Sell |
|
|||||
|
2023
Q1 | $5.22M | Sell |
|
|||||
|
2022
Q4 | $6.18M | Buy |
|
|||||
|
2022
Q3 | $10.1M | Buy |
|
|||||
|
2022
Q2 | $15M | Sell |
|
|||||
|
2022
Q1 | $24.2M | Sell |
|
|||||
|
2021
Q4 | $25.7M | Sell |
|
|||||
|
2021
Q3 | $29.8M | Buy |
|
|||||
|
2021
Q2 | $32.9M | Buy |
|
|||||
|
2021
Q1 | $46.9M | Sell |
|
|||||
|
2020
Q4 | $46.6M | Sell |
|
|||||
|
2020
Q3 | $55.6M | Sell |
|
|||||
|
2020
Q2 | $42.7M | Buy |
|
|||||
|
2020
Q1 | $30.6M | Sell |
|
|||||
|
2019
Q4 | $29.9M | Sell |
|
|||||
|
2019
Q3 | $30.5M | Sell |
|
|||||
|
2019
Q2 | $29.3M | Sell |
|
|||||
|
2019
Q1 | $39.3M | Sell |
|
|||||
|
2018
Q4 | $47.3M | Sell |
|
|||||
|
2018
Q3 | $56.1M | Buy |
|
|||||
|
2018
Q2 | $38.2M | Buy |
|
|||||
|
2018
Q1 | $38.9M | Buy |
|
|||||
|
2017
Q4 | $26.6M | Buy |
|
|||||
|
2017
Q3 | $22.4M | Sell |
|
|||||
|
2017
Q2 | $19.2M | Buy |
|
|||||
|
2017
Q1 | $16.2M | Sell |
|
|||||
|
2016
Q4 | $23.4M | Buy |
|
|||||
|
2016
Q3 | $21.6M | Buy |
|
|||||
|
2016
Q2 | $18.8M | Sell |
|
|||||
|
2016
Q1 | $49.2M | Sell |
|
|||||
|
2015
Q4 | $74.3M | Sell |
|
|||||
|
2015
Q3 | $67.6M | Sell |
|
|||||
|
2015
Q2 | $91.2M | Sell |
|
|||||
|
2015
Q1 | $84.2M | Buy |
|
|||||
|
2014
Q4 | $79.1M | Sell |
|
|||||
|
2014
Q3 | $71.2M | Sell |
|
|||||
|
2014
Q2 | $76M | Buy |
|
|||||
|
2014
Q1 | $85M | Buy |
|
|||||
|
2013
Q4 | $73.1M | Sell |
|
|||||
|
2013
Q3 | $63.2M | Sell |
|
|||||
|
2013
Q2 | $49.3M | Buy |
|